Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute is a clinical research site located in Los Angeles, California, United States 90048.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has participated in 21 clinical trials with 6 currently active.
Therapeutic areas: Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate.
Sponsors: Pfizer, John Mascarenhas, Millennium Pharmaceuticals, Inc..
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute has 21 clinical trials on record, with 6 currently active. Their work covers Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate.
Yes — Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.